- Home
- IQV vs CUK Comparison
IQV vs CUK Comparison
Compare IQV & CUK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- CUK
- Stock Information
- Founded
- IQV 1982
- CUK 1972
- Country
- IQV United States
- CUK United States
- Employees
- IQV N/A
- CUK N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- CUK Marine Transportation
- Sector
- IQV Health Care
- CUK Consumer Discretionary
- Exchange
- IQV Nasdaq
- CUK Nasdaq
- Market Cap
- IQV 35.7B
- CUK 29.6B
- IPO Year
- IQV 2013
- CUK 2000
- Fundamental
- Price
- IQV $200.02
- CUK $24.59
- Analyst Decision
- IQV Strong Buy
- CUK Buy
- Analyst Count
- IQV 17
- CUK 18
- Target Price
- IQV $254.50
- CUK $26.78
- AVG Volume (30 Days)
- IQV 1.4M
- CUK 1.7M
- Earning Date
- IQV 02-06-2025
- CUK 03-26-2025
- Dividend Yield
- IQV N/A
- CUK N/A
- EPS Growth
- IQV 27.98
- CUK N/A
- EPS
- IQV 7.62
- CUK 1.44
- Revenue
- IQV $15,315,000,000.00
- CUK $25,021,000,000.00
- Revenue This Year
- IQV $3.67
- CUK $7.75
- Revenue Next Year
- IQV $4.40
- CUK $3.60
- P/E Ratio
- IQV $26.13
- CUK $18.32
- Revenue Growth
- IQV 3.10
- CUK 15.88
- 52 Week Low
- IQV $187.62
- CUK $12.50
- 52 Week High
- IQV $261.73
- CUK $26.14
- Technical
- Relative Strength Index (RSI)
- IQV 47.86
- CUK 58.99
- Support Level
- IQV $195.99
- CUK $24.03
- Resistance Level
- IQV $204.10
- CUK $26.14
- Average True Range (ATR)
- IQV 4.78
- CUK 0.80
- MACD
- IQV -0.26
- CUK 0.19
- Stochastic Oscillator
- IQV 40.84
- CUK 60.05
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About CUK Carnival Plc ADS ADS
Carnival is the largest global cruise company, with more than 90 ships in service at the end of fiscal 2024. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It's currently folding its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted 14 million guests in 2024.